Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.9M Buy
453,842
+130,871
+41% +$8.01M 14.51% 2
2026
Q1
$22.4M Buy
322,971
+47,000
+17% +$3.62M 13.06% 3
2025
Q4
$21M Sell
275,971
-29,500
-10% -$2.37M 11.82% 4
2025
Q3
$26.3M Sell
305,471
-45,500
-13% -$3.43M 15.12% 2
2025
Q2
$23.9M Sell
350,971
-323,000
-48% -$20M 12.22% 3
2025
Q1
$40.1M Sell
673,971
-89,984
-12% -$5.7M 22.4% 1
2024
Q4
$46.2M Buy
763,955
+155,700
+26% +$9.53M 22.32% 1
2024
Q3
$43.8M Buy
608,255
+230,980
+61% +$16.1M 21.38% 2
2024
Q2
$26.6M Buy
+377,275
New +$29M 11.97% 4
2020
Q2
Sell
-10,000
Closed -$492K 10
2020
Q1
$492K Buy
+10,000
New +$784K 0.28% 15

Other funds holding APTV

Alex Roepers's APTV Position: Q2 2026 in Review

Alex Roepers increased its Aptiv (APTV) stake by 41% in Q2 2026, buying an estimated $8.01M and bringing the position to 453,842 shares worth $27.9M. The position accounts for 14.51% of the portfolio, ranked #2.

Alex Roepers first reported a position in APTV in Q1 2020 and has held it in 10 quarters since. The position peaked at $46.2M in Q4 2024. 655 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • Alex Roepers held 453,842 shares of Aptiv worth $27.9M as of Q2 2026.
  • Alex Roepers bought 130,871 Aptiv shares in Q2 2026, an estimated $8.01M.
  • Aptiv made up 14.51% of Alex Roepers's portfolio in Q2 2026, its #2 holding.
  • Alex Roepers first reported a position in Aptiv in Q1 2020 and has held it in 10 quarters since.
  • Alex Roepers's Aptiv position peaked at $46.2M in Q4 2024.
  • 655 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on Atlantic Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.